Combining in the melt physical and biological properties of poly(caprolactone) and chlorhexidine to obtain antimicrobial surgical monofilaments by Scaffaro, R. et al.
BIOTECHNOLOGICAL PRODUCTS AND PROCESS ENGINEERING
Combining in the melt physical and biological properties
of poly(caprolactone) and chlorhexidine to obtain
antimicrobial surgical monofilaments
R. Scaffaro & L. Botta & M. Sanfilippo & G. Gallo & G. Palazzolo & A. M. Puglia
Received: 30 May 2012 /Revised: 2 July 2012 /Accepted: 3 July 2012 /Published online: 21 July 2012
# Springer-Verlag 2012
Abstract Bacterial infections on a sutured wound represent
a critical problem, and the preparation of suture threads
possessing antimicrobial properties is valuable. In this work,
poly(caprolactone) (PCL) monofilaments were compounded
at the concentration of 1, 2 and 4 % (w/w), respectively, to
the antiseptic chlorhexidine diacetate (CHX). The incorpo-
ration was carried out in the melt by a single-step method-
ology, i.e. “online” approach. Mechanical tests revealed that
the incorporation of CHX does not significantly change
tensile properties of PCL fibres as the thermal profile adop-
ted to prepare the compounded fibres does not compromise
the antibacterial activity of CHX. In fact, CHX confers to
compounded PCL fibres’ antimicrobial property even at the
lowest CHX concentration as revealed by microbiological
assays performed on Escherichia coli, Micrococcus luteus
and Bacillus subtilis strains. The scanning electron micro-
scope micrographs and energy-dispersive X-ray analysis of
compounded threads revealed that CHX is uniformly dis-
tributed on fibre surface and that the overall amount of
superficial CHX increases by increasing compounded
CHX concentration. This distribution determines a biphasic
CHX release kinetics characterized by an initial rapid sol-
ubilisation of superficial CHX micro-crystals, followed by a
slow and gradual release of CHX incorporated in the bulk.
Interestingly, the compounded threads did not show any
toxic effect compromising cell viability of human fibro-
blasts in vitro, differently from that observed using an
equal amount of pure CHX. Thus, this study originally
demonstrated the effectiveness of an “online” approach
to confer antimicrobial properties to an organic thermo-
plastic polymeric material commonly used for medical
devices.
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Introduction
Bacterial contamination is a problem that concerns a wide
variety of materials used for biomedical applications.
Generally, an alien material in the body provokes an im-
mune and/or inflammatory response at different intensity
levels. This is particularly true for surgical suture threads.
In contact with the wound, suture threads are quickly coated
with proteins-rich fluids, like fibrinogen and fibronectin,
which create the ideal environment for the proliferation of
microorganisms infecting the surgical site. The bacterial
infection in the contaminated suture triggers immune system
cells, usually granulocytes, that may be ineffective to con-
trast the infection and that result in local inflammatory
reaction (Masini et al. 2011). Thus, additional therapies
based on antibiotics and anti-inflammatory drugs are often
required determining a further systemic burden, due to
physiological detoxification and/or side effects, and even
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an increment of healthcare costs (Leaper et al. 2011).
Alternatively, the active drug could be part of the suture
thread, being effective on-site reducing systemic consequen-
ces. Providing a suture thread or, generally, a polymeric
article with antimicrobial properties can be achieved by
different routes (Kenawy et al. 2007; Zhukovskii et al.
2007).One approach is to provide the polymer with antimi-
crobial properties in an "offline" preparation process. In this
case, the thread is superficially coated using a specific
antimicrobial component previously dissolved in a solvent
(Blaker et al. 2004; Dubas et al. 2011; Harnet et al. 2009;
Gupta et al. 2007, 2008; Pollini et al. 2009; Saxena et al.
2011; Zurita et al. 2006). Another approach is to add the
biocide agent in the polymers "online", i.e. during either the
preparation/forming in solution (Hu et al. 2010; Liu et al.
2010) or in the melt (Douglas et al. 2010; Nostro et al. 2010,
2012; Perale et al. 2010; Scaffaro et al. 2011, 2012). Online
methods are preferred because the processing temperatures
to synthesize or melt polymers are usually lower than the
decomposition/deactivation temperature of the antimicrobial
agent. Furthermore, melt processing has the advantage to
use equipment commonly used to process thermoplastic
materials, thus ensuring large production volumes and sol-
ventless environments. Therefore, the overall environmental
impact is decreased, the costs reduced and the presence of
solvents/by-products in the thread which can then be
absorbed by the organism minimized. Poly(caprolactone)
(PCL) is an aliphatic synthetic biodegradable polyester,
frequently used in biomedical applications for drug con-
trolled release (Douglas et al. 2010; Guillaume et al. 2011;
Luong-Van et al. 2006; Teo et al. 2011), absorbable suture
threads (Barber and Click 1992; Charuchinda et al. 2003;
Liu et al. 2010; Perale et al. 2010) and tissue engineering
(Choong et al. 2012; Croisier et al. 2012; Li et al. 2003).
Chlorhexidine (CHX) is an antibacterial agent active to
both Gram-positive and Gram-negative bacterial strains as
well as to fungi in a dose-dependent manner (McDonnell
and Russell 1999; Russell and Day 1993). It is usually used
for its antiseptic and disinfectant action on wounds, in
several products for oral protection and, in general, for
dentistry applications (Arnold et al. 2008; Fong et al.
2010; Hiraishi et al. 2008; Huynh et al. 2010; Leung et al.
2005).
In order to prepare monofilaments to be applied as
threads for surgical sutures and possessing antimicrobial
properties, an “online” method was used to combine the
physicochemical and biological property of PCL and
CHX, respectively. The effect of CHX amount on the anti-
microbial properties, release kinetic and on the mechanical
performance was tested by using microbiological and chem-
ical–physical methodologies. In addition, a possible toxic
effect of compounded threads on human cells was evaluated
in vitro by monitoring cell viability.
Materials and methods
Materials and preparation
PCL (Mn070,000–90,000 gmol−1 by GPC, Tm060 °C,
density01.145 g/ml at 25 °C) and CHX (chemical formula:
C22H30Cl2N10· (C2H4O2)2, Tm0155 °C, water solubility0
19 mg/ml) were purchased from Sigma-Aldrich.
CHX was added to PCL at 1, 2 and 4 % (w/w) at the solid
state, and then the mixture was fed to a counter-rotating twin
screw compounder (Brabender, D045 mm, L/D07) with a
thermal profile of 40–50–70–100 °C and a speed of 64 rpm.
In order to prevent hydrolytic scissions during processing,
PCL was dried under vacuum at 40 °C for about 24 h
according to previous studies (Charuchinda et al. 2003;
Perale et al. 2010).
PCL and PCL/CHX blends were spun after drying at
40 °C for 6 h by using a capillary rheometer (Rheoscope
1000, CEAST Italy) equipped with a capillary having D0
1 mm and L/D040. More in detail, a piston pressed the
molten polymer from a cylindrically shaped reservoir to the
capillary above described. At the exit of the capillary, the
filament was drawn at constant speed and free cooling at
room temperature using a collecting pulley rotating at
10 rpm. Under these conditions, the threads had a diameter
of 300±10 μm.
Characterization of CHX-compounded PLC fibres
Morphology
The morphology of the fibres and of neat CHX was ana-
lyzed by a scanning electron microscope (SEM) (Quanta
200F ESEM, FEI, Hillsboro, USA). All samples were
sputter-coated with a thin layer of gold to avoid electrostatic
charging under the electron beam. Moreover, energy-
dispersive X-ray (EDX) analysis was performed on some
samples with the same apparatus.
Mechanical characterization
Tensile tests (ASTM D882) of fibres (at least seven repli-
cates) were carried out by using a dynamometer (Instron
Model 3365, Instron, UK). The grip distance was 30 mm,
while the tensile speed was 1 mm/min for the first 2 min and
100 mm/min thereafter. The data are reported as means±SD.
CHX release
A series of CHX solutions of distilled water containing 0.1
thru 1.5 mg/dL of CHX was used to obtain a calibration
curve correlating the absorbance peak intensity and the
CHX concentration using a UV/vis spectrophotometer
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(model UVPC 2401, Shimadzu Italia s.r.l., Milan, Italy). In
the concentration range here investigated, the calibration
curve was found to be a line (Supplementary Fig. S1). The
maximum absorbance peak of CHX was detected at 260 nm
in full accordance with the scientific literature (Hiraishi et al.
2008). The release of CHX from the fibres was investigated
by immersing a pre-weighed sample (approximately 12 mg,
14 cm long) in 8 ml of distilled water. At specific time
intervals, the absorbance peak intensity at 260 nm of the
storage solutions was measured and converted to the quan-
tities of CHX released based on the calibration line. After
each measurement, the samples were immersed in 8 ml of
fresh distilled water, and the cumulative release of CHX
here reported was calculated by sequentially adding the
CHX released after each step.
Microbiological assays
Micrococcus luteus ATCC 10240, Bacillus subtilis ATCC
6633 and Escherichia coli DH5αTM (Invitrogen) were used
as tester strains.
Agar diffusion tests
For each tester strain, a bacterial suspension of 108 colony-
forming units (CFU) was inoculated into 5 ml of LB soft
Fig. 1 SEM micrographs of
filament surfaces at two
different magnifications: a, b
PCL+1 % CHX; c, d PCL+2 %
CHX; e, f PCL+4 % CHX
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agar to obtain a uniform bacterial overlay on LB agar plates.
PCL fibres containing CHX at 1, 2 and 4 % (w/w) were
placed over tester overlay. Neat PCL fibres, discs of 3-mm
paper (Whatman) imbibed by 10 μg of pure CHX or 10 μg
of pure CHX treated for 2 min at 100 °C were used as
controls. Growth inhibition halos were observed after
overnight incubation at 37 °C.
Colony-forming unit plate counting
For each tester strain, 2 ml of LB broth containing a
bacterial suspension at the concentration of 106 CFU/ml
was incubated in sterile test tubes with 2 mg PCL fibres
containing CHX at 1, 2 and 4 %. Parallel control culti-
vations were performed without PCL fibres or adding:
neat PCL fibres, 10 μg/ml of pure CHX or 10 μg/ml of
pure CHX treated for 2 min at 100 °C. After 18 and 24 h
of incubation at 37 °C in an orbital shaker (200 rpm), the
number of bacterial viable cells was determined by
plating aliquots of 100 μl of serial dilutions on LB agar
plates and incubating overnight at 37 °C for CFU
counting.
Toxicity tests
Human fibroblast culture
Human IMR90 fibroblasts (ATCC CCL-186) were used as
tester cells to evaluate toxicity of CHX-embedded PCL
fibres. Cells were seeded in 24-well plates (104 cells/well)
and cultured in a humidified incubator with 5 % CO2 at
37 °C using 2 ml Minimum Essential Medium (Sigma)
supplemented with 10 % foetal bovine serum (Gibco, EU
approved, Invitrogen, Italy), 2 mM L-glutamine, 100 U/ml
penicillin, 0.1 mg/ml streptomycin, 1 mM sodium pyruvate
and non-essential amino acids (Invitrogen, Italy). Four-day
grown cells at about 80–90 % of confluence were then
incubated for 24 h in the presence of 2 mg PCL fibres
compounded with 4 % CHX and tested for viability. As
the control, cells were incubated in the absence of PCL fibre
or in the presence of: neat PCL fibre, pure CHX (40 μg/ml)
or pure 100 °C-treated CHX (40 μg/ml). Each cultivation
was performed in quadruplicate.
Viable cell determination by differential fluorescent staining
assay
Cell viability and integrity was tested by a combination of
two fluorescent DNA-binding dyes, acridine orange and
ethidium bromide (AO/EB), as previously described
(Martin and Leonardo 1994). In brief, 24 h after 4 % CHX
PCL fibre exposure, spent medium was removed, and cells
were stained with a 100-μl AO/EB mixture, each at a
concentration of 100 μg/ml in phosphate-buffered saline
(PBS). The differential uptake of the two dyes allowed the
identification of viable and non-viable cells by fluorescence
microscopy. Acridine orange permeates throughout the
cells and renders the nuclei bright green. Ethidium
bromide penetrates slowly intact cells, while it is rapidly
uptaken by cells whose cytoplasmic membrane integrity
is compromised, and thus, it stains the nuclei bright red.
Cells from duplicated parallel cultivations were observed
by fluorescence inverted microscopy (Axio, USA), and
images were analyzed by Vision software (Axio). For
quantitative analysis, cell fields were randomly chosen,
and five images were analysed for each well. The
Fig. 2 Cumulative CHX
release expressed as
micrograms per milligram of
filaments containing different
concentrations of CHX
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values are shown as ratio of viable /total cells, and data
are reported as means±SD.
Viable cell counting by trypan blue exclusion assay
Cell viability was further quantitatively determined by
trypan blue exclusion assay (Mishell and Shiigi 1980).
After 24 h of 4 % CHX PCL fibre exposure, cells were
collected by trypsinization and stained with 0.4 % trypan
blue solution in PBS. Viable versus total cells, from dupli-
cated parallel cultivations, were manually counted in a
hemocytometer under an inverted light microscope with
×20 magnification. The trypan blue dye is normally taken
up by non-viable cells but not by viable cells because it only
penetrates through damaged cellular membranes. Cell
viability was calculated as the percentage of viable cells
compared to the total number of counted cells. Three inde-
pendent counts were performed for each cultivation, and
data are reported as means±SD.
Results
Morphological and physical characterization
of CHX-compounded PCL fibres
CHX was compounded to PCL at the concentrations of 1, 2
and 4 % (w/w) by using a counter-rotating twin screw
compounder. Spun threads were then obtained by using a
capillary rheometer (See Supplementary Fig. S2 for the
morphology of neat PCL). CHX additive forms crystalline
aggregates uniformly on the surface of the compounded
PCL threads at all the three CHX concentrations as SEM
micrographs revealed (Fig. 1; Supplementary Fig. S3). In
particular, the overall amount of superficial CHX increases
by increasing CHX concentration, and at the highest
concentration, a crowded pattern of crossed CHX micro-
crystals occurs (Fig. 1f).
In order to investigate the relationship between surface
distribution and CHX release in an aqueous solution, release
Fig. 4 Elastic modulus (E),
tensile stress (TS) and
elongation at break (EB) of
all the filaments prepared
Fig. 3 SEM micrographs
together with the EDX spectra
of the 4 % CHX-compounded
PCL filament (a) and after (b)
7 days of storage in distilled
water
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kinetics in distilled water was measured (Fig. 2). According
to the CHX surface distribution, increasing CHX amount in
the compounded fibres led to an increased CHX release
during time. Thus, the higher availability of CHX on the
thread surface of the fibres containing 4 % of CHX results in
a higher amount of ready-to-be solubilized compound. This
result was further confirmed by SEM analysis together with
the EDX spectra of a 4 % CHX thread untreated (Fig. 3a)
and after 7 days of immersion in distilled water (Fig. 3b). In
fact, the EDX spectrum of untreated threads shows the
Fig. 6 M. luteus cultivations in
liquid broth after a 24-h exposure
to CHX-compounded PCL
fibres. The fibres were immersed
in a liquid medium containing a
starting number of 106 bacteria/ml.
Similar results were obtained
for E. coli and B. subtilis
(data not shown)
Fig. 5 Agar diffusion test
performed onM. luteus overlay.
PCL fibres containing CHX at
1, 2 and 4 % (w/w) were placed
over tester overlay. Bacterial
growth inhibition halos were
observed around all CHX-
compounded PCL fibres after
an overnight incubation at
37 °C. Neat PCL fibres, discs of
3-mm paper imbibed by 10 μg
of pure CHX or 10 μg of pure
CHX treated at 100 °C pure
CHX were used as controls.
Similar results were obtained
for E. coli and B. subtilis used
as tester strains (data not
shown)
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presence of N and Cl (Fig. 3) due to superficial CHX as
SEM micrograph and the comparison with the EDX spec-
trum of neat CHX reveals (Supplementary Fig. S4). After
7 days of immersion in water, the EDX spectrum does not
show the presence of N and Cl, and in the SEM micro-
graphs, there are evident cavities, likely to be due to CHX
micro crystals leached during immersion in water.
In order to verify if the CHX incorporation caused some
modification of the mechanical performance of the materi-
als, thus inhibiting or reducing the possible practical use,
tensile mechanical testing was performed, Fig. 4. This
analysis revealed that the observed variation of the elastic
modulus (E), the tensile stress (TS) and the elongation at break
(EB) of all the compounded threads are very small even at the
highest CHX concentration used. In particular, the increase of
CHX content coincides with a slight increase of E and a slight
decrease of TS and EB parameters. Anyway, these variations
(about 12 % at last) are small and have poor significance in
terms of mechanical performance variations.
Antimicrobial activity of CHX-compounded PCL fibres
The presence of CHX on the polymer surface is compatible
with potential antimicrobial activity of the fibres. To verify
biological property, agar diffusion tests were performed
using the compounded spun fibres against three tester
strains, the Gram-positive M. luteus and B. subtilis and the
Gram-negative E. coli, which are reported to be sensitive to
chlorhexidine (Dance et al. 1987; Hammond et al. 1987).
The presence of inhibition growth halos was observed for all
the three tester strains around spun fibres compounded with
1, 2 and 4 CHX (Fig. 5). In addition, inhibition zone areas
around 1 and 2 % CHX-compounded fibres seemed similar,
while a net enlargement of inhibition zone was observed
using 4 % CHX spun fibres. Therefore, this analysis sug-
gests that 1 and 2 % CHX fibres release a similar antibiotic
amount, while 4 % CHX spun fibres release an increased
amount of antibiotic. This evidence is in agreement with the
results of CHX release kinetics (Fig. 2).
Moreover, the CHX used as positive control showed no
or negligible change of the inhibition halo after a thermal
treatment at 100 °C for 2 min, i.e. under the same conditions
adopted to prepare the threads.
Furthermore, in order to perform the counting of viable
bacterial cells after CHX-compounded fibre exposure, the
fibres were immersed in liquid cultures. In particular, bac-
terial cultivations were performed inoculating separately the
tester strains in the presence of the three kinds of CHX-
compounded spun fibres, respectively (Fig. 6). The quanti-
tative data obtained by counting the number of bacterial
viable cells as CFU after 18- and 24-h exposure to CHX-
compounded PCL fibres showed a drastic decrease of the
number of viable cells in all cultivations containing 1, 2 and
4 % CHX spun fibres in respect of starting amount of
inoculated bacteria (Fig. 7). This is consistent with the
bactericidal effect of CHX released by compounded PCL
fibres on all tester strains. Actually, it can be also observed
that even if the growth inhibition is evident at all the
Fig. 7 Counting of bacterial viable cells as colony-forming units
(CFU). After 18- and 24-h exposure to CHX-compounded PCL fibres,
100-μl aliquots from serial dilutions ofM. luteus, B. subtilis and E. coli
cultivations were plated on LB agar medium, respectively. After an
overnight incubation at 37 °C, the total number of colonies was
counted and reported as CFU per millilitre
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concentrations, the fibres containing 4 % CHX display the
best and fastest activity if compared with those containing 1
or 2 % of additive likely because of the different release
kinetics of CHX.
Toxic effect in vitro evaluation of CHX-compounded PCL
fibres on human cells
In order to assess the possible effects of CHX-compounded
spun fibres on human cells, cell viability in vitro assays
were performed. For this purpose, human fibroblast
IMR90 cells, routinely used as tester cell line for toxicity
assays, were exposed for 24 h to 4 % CHX spun fibres
(AshaRani et al. 2009; Oh et al. 2010). In parallel, cells
incubated with/without neat spun PCL fibres were used as
negative controls, while cells maintained in the presence of
pure CHX or 100 °C-treated CHX (the same amount of the
one incorporated in 4 % CHX fibres used in this experi-
ment) were used as positive controls.
Interestingly, trypan blue exclusion assay revealed that
4 % CHX spun fibre exposure does not impair cell viability
in comparison with the negative controls, while exposure to
pure CHX or 100 °C-treated CHX reduces cell viability to
1 % (Fig. 8), accordingly to what has been reported in
previous studies (Chang et al. 2001; Hidalgo et al. 2001).
This result was confirmed by cell morphology and integrity
inspection based on differential AO/EB staining. In partic-
ular, Fig. 9a indicates that cell morphology and ethidium
bromide penetration into human cells exposed to 4 % CHX-
compounded fibres are similar to the negative controls. On
the other hand, severe damages, necrotic morphology and
high penetration of ethidium bromide were revealed in cells
incubated in the presence of CHX and 100 °C-treated CHX.
In fact, 4 % CHX spun fibre does not exert toxic effects on
cell viability. Quantitative data from AO/EB-stained cells
are essentially in agreement with trypan blue exclusion
assay results, showing, respectively, 96, 97 and 95 % of cell
integrity in negative control and cells exposed to neat and
4 % CHX spun fibres (Fig. 9b). Furthermore, no intact cells
were revealed after exposure to pure CHX or 100 °C-treated
CHX.
Discussion
To the best of our knowledge, this study demonstrated for
the first time the effectiveness of an “online” approach to
confer antimicrobial properties to an organic thermoplastic
polymeric material commonly used for medical devices.
CHX-compounded PCL fibres were found to combine the
physical–chemical and biological properties of PCL, a
low-melting point polymeric material, and of CHX, a
potent antimicrobial agent, respectively. PCL and CHX
were also chosen for their large use in biomedical appli-
cations; anyway, the online approach here described can
be extended to prepare suture materials using different
polymers to be compounded to different antimicrobial
agents.
The compounded fibres acquired powerful antimicrobial
activity that did not compromise the overall mechanical
performance of threads. In fact, the variations in tensile
properties are very small even at the highest CHX concen-
tration used, and this is likely to be due to the good and
uniform dispersion of the CHX preventing the formation of
aggregates that could cause decreased mechanical properties
of the threads. On the other hand, the thermal profile adop-
ted to prepare the compounded fibres does not compromise
the antibacterial activity of CHX since 100 °C-treated CHX
used in biological assay showed no or negligible change in
comparison with non-treated CHX.
Fig. 8 Viable cell counting by
trypan blue exclusion assay
performed on human fibroblasts
after a 24-h exposure to 4 %
CHX fibres
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The release of CHX from the monofilaments is charac-
terized by an initial phase with a rapid solubilisation of
superficial CHX micro-crystals, followed by a second phase
which is characterized by a slow kinetic achieving its pla-
teau after 1 week. The SEM micrographs of compounded
threads coupled with EDX analysis revealed that CHX,
incorporated in the melt, is uniformly distributed onto the
fibre surface and that the overall amount of superficial CHX
increases by increasing compounded CHX concentration. In
fact, bacterial growth inhibition is evident at all com-
pounded CHX concentrations with the fibres containing
4 % CHX displaying the best and fastest activity. Thus,
higher availability of CHX on the thread surface results in
higher amounts of ready-to-be solubilized compound. The
CHX availability on the fibre surface can be probably con-
sidered the cause of the initial burst effect revealed in the
kinetic release study. The second phase of CHX release may
be due to a water-dependent relaxation of the PCL matrix
that allows the exposition of the internal CHX. This char-
acteristic of compounded threads may be of interest since
the bursting drug release can be useful to inhibit bacterial
spreading at the beginning of wound cleansing. The follow-
ing phase, with a slow and progressive release of the addi-
tive, grants the extension of the antibacterial activity.
Interestingly, the threads containing the highest CHX
level did not show in vitro any toxic effect compromising
cell viability, differently from that observed using an equal
amount of pure CHX. CHX activity is due to cytoplasmic
membrane damage that leads to permeability alteration and
eventually to cell death. This mode of action determines
efficacy on both prokaryotic and eukaryotic cells in a
dose-dependent manner (Russell and Day 1993). In partic-
ular, at concentrations of 0.1–1 and 2–2.5 μg/ml, chlorhex-
idine has a bacteriostatic effect against most Gram-positive
bacteria and many Gram-negative bacteria, respectively
(Dance et al. 1987; Hammond et al. 1987). At CHX con-
centrations of 10–20 μg/ml or more, a bactericidal effect can
be expected as well as inhibitory growth property against
yeasts (Russell and Day 1993). Studies evaluating in vitro
toxicity on human cell revealed that CHX concentrations
greater than 0.0001 % significantly compromise cell viabil-
ity after a 24-h exposure (Chang et al. 2001; Hidalgo et al.
2001). On the other hand, neither antibiotic nor toxic effect
is reported for PCL. The results of trypan blue exclusion
assay and cell morphology and integrity inspection based
on differential AO/EB staining showed that the exposure
to fibre incorporating the higher amount of CHX does
not impair cell viability, while exposure to pure CHX or
100 °C-treated CHX reduces cell viability to 1 %, ac-
cordingly to what has been reported in previous studies
(Chang et al. 2001; Hidalgo et al. 2001). This finding
might be due to the CHX release kinetics from com-
pounded PCL fibres. In fact, since CHX effect on eucarya
cells is dose-dependent, a gradual release could allows cells
to counteract possible damages. Therefore, the use of
CHX-compounded fibres may confer a real advantage over
the use of an equal amount of free CHX as antiseptic
following surgical sutures.
Although many aspects of the use of CHX-compounded
fibres for human surgical application have not yet been
clarified, this study provides promising results that need to
be further corroborated. Therefore, further in vivo studies
have to be performed to address the possible use of CHX-
compounded PCL fibres for surgical applications.
Fig. 9 Human fibroblast cell integrity by differential acridine orange/
ethidium bromide staining. a Cell morphology and ethidium bromide
penetration into human cells after 24 h of exposure. b Quantitative data
of cell integrity
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